SUN 0597
Alternative Names: S-0597; S-597; SPARC-1316; SUN-597; SUN-S597; SUN0597Latest Information Update: 23 Aug 2019
At a glance
- Originator Sun Pharma Advanced Research Company
- Class Anti-inflammatories; Glucocorticoids
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Allergic conjunctivitis; Asthma; Atopic dermatitis; Inflammation; Psoriasis; Seasonal allergic rhinitis
Most Recent Events
- 23 Aug 2019 Discontinued - Phase-I for Asthma in USA (Inhalation)
- 23 Aug 2019 Discontinued - Phase-I for Inflammation (In volunteers) in India (Intranasal)
- 23 Aug 2019 Discontinued - Phase-I/II for Asthma in United Kingdom (Inhalation)